If you're on Medicare and have been curious about GLP-1 medications like Wegovy or Zepbound for weight loss, there's good news worth knowing about. Starting July 1, 2026, a new program called the Medicare GLP-1 Bridge is giving eligible beneficiaries access to certain weight-loss medications for a flat $50 monthly copay. For many older adults, this is the first time Medicare has ever helped cover the cost of a drug prescribed specifically for weight management.

This is a big shift, and it's understandable if you have questions. Below, we'll walk through what the program is, who qualifies, what it costs, and how to find out if it's right for you — in plain language, without the confusing insurance jargon.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a short-term demonstration program run directly by the Centers for Medicare & Medicaid Services (CMS). It runs from July 1, 2026, through December 31, 2027, and gives eligible people with Medicare prescription drug coverage (Part D) access to select GLP-1 medications for weight loss.

It's important to understand that this program works outside of your regular Part D drug benefit. Instead of going through your plan's usual formulary and cost-sharing rules, a central system run by Medicare handles the approvals, processes claims, and pays the pharmacy directly. Your Part D plan doesn't have to "opt in," and it doesn't carry financial risk for these prescriptions.

Why is Medicare doing this now? Historically, federal law has prohibited Part D plans from covering medications prescribed purely for weight loss — even though the same drugs are often covered when prescribed for conditions like type 2 diabetes. GLP-1 medications have become widely known for helping people lose meaningful amounts of weight, and this demonstration is meant to test broader, more affordable access while a longer-term solution is worked out. Making that kind of permanent change would require an act of Congress.

Which Weight-Loss Medications Are Covered?

Not every GLP-1 medication is included. The Bridge program covers three weight-management drugs specifically:

You may notice that Ozempic and Mounjaro aren't on this list — that's because those are the versions of the same drug classes approved specifically for type 2 diabetes, and Medicare may already cover them under your regular Part D benefit if you have diabetes.

Who Qualifies for Coverage?

Eligibility is based mainly on your body mass index (BMI) and any related health conditions. In general, to qualify you'll need to:

• Have Medicare prescription drug coverage, either through a standalone Part D plan or a Medicare Advantage plan that includes drug coverage
• Meet specific weight and health criteria — generally a BMI in the overweight or obese range, along with a weight-related condition such as prediabetes, uncontrolled high blood pressure, heart disease, or chronic kidney disease
• Not already have Medicare coverage for a GLP-1 through a different diagnosis, such as type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease
• Get prior authorization approval through the Bridge Program, which your prescriber submits on your behalf

If you're already taking a GLP-1 for weight loss, you may still qualify. Your prescriber can attest that you met the clinical criteria when you first started the medication, even if your weight (and BMI) has since changed for the better.

One detail worth knowing: if you receive Extra Help (the Medicare low-income subsidy), that assistance cannot be applied to medications covered under the Bridge program.

How Much Will You Pay?

Under the Bridge program, eligible beneficiaries pay a flat $50 copay for a one-month supply, no matter the dose. That's a significant change from the hundreds of dollars per month many people currently pay out of pocket for these medications.

A few important details to keep in mind:

• The $50 copay does not count toward your Part D deductible
• It also does not count toward the annual $2,100 out-of-pocket cap on prescription drugs
• This is a temporary demonstration, currently scheduled to run only through December 31, 2027

Even with those caveats, $50 a month is far more predictable and manageable for most people than paying full price.

How to Get Started

If this program sounds like it could apply to you, here are some simple next steps:

1. Schedule a visit with your primary care provider. They can review your health history, calculate your BMI, and talk with you about whether a GLP-1 medication is a good fit for your goals and overall health.
2. Ask about prior authorization. Your provider will need to submit documentation to the Bridge Program on your behalf — this is a required step, not optional paperwork you can skip.
3. Confirm your Part D coverage is active. You'll need to be enrolled in a Part D plan or a Medicare Advantage plan with drug coverage.
4. Be patient with timing. Because so many people are expected to apply at once, some clinics and pharmacies may experience delays in the first few months. Don't be discouraged if it takes a little longer than expected to get started.
5. Call for help if you have questions. The Medicare Rights Center helpline (800-333-4114) and your local State Health Insurance Assistance Program (SHIP, at shiphelp.org) can walk you through your specific situation privately and at no cost.

Benefits Beyond the Scale

For many people, weight loss is only part of the story. GLP-1 medications have also been associated with improvements in blood sugar control, blood pressure, joint pain, and cardiovascular risk factors like the chances of heart attack or stroke. If you're carrying extra weight that's affecting your energy, mobility, or overall health, this may be an opportunity to make meaningful progress — with medical support every step of the way.

That said, medication works best as one part of a broader plan. Pairing treatment with small, sustainable lifestyle habits — like a short daily walk, more vegetables at dinner, or better sleep — can help support your results and your long-term well-being.

What to Keep in Mind

As exciting as this program is, it's worth going in with realistic expectations:

• This is a temporary, time-limited demonstration — not a permanent Medicare benefit
• Research shows many people who stop taking GLP-1 medications regain some of the weight they lost, so it's worth discussing a long-term plan with your provider
• Coverage after December 2027 is not yet guaranteed and will depend on future policy decisions
• Because demand is expected to be high, appointments and approvals may take extra time in the months right after launch

Frequently Asked Questions

When does the Medicare GLP-1 Bridge Program start?

The program began on July 1, 2026, and is scheduled to run through December 31, 2027.

Do I need a special enrollment to join the Bridge Program?

No separate enrollment is required. If you already have Medicare Part D or a Medicare Advantage plan with drug coverage, your provider can submit a prior authorization request on your behalf when the time comes.

Is this the same as my regular Part D drug coverage?

No. The Bridge Program operates outside your normal Part D benefit. It's a separate, centrally administered system, which is why the costs and rules (like the $50 copay not counting toward your deductible) work differently than your usual prescriptions.

What if I already take a GLP-1 for diabetes?

If you're already getting a GLP-1 covered through Medicare for type 2 diabetes, sleep apnea, or fatty liver disease, you generally won't need the Bridge Program, since that coverage already exists under your regular benefit.

Will my BMI need to stay the same to keep coverage?

No. If you started a GLP-1 before the program began and met the criteria at that time, your prescriber can attest to your original BMI and health status, even if your weight has since improved.

Can I use Extra Help (the low-income subsidy) to reduce the $50 copay?

No. Medications covered under the Bridge Program are not eligible for Extra Help assistance.

What happens when the program ends in December 2027?

That's still uncertain. Policymakers are exploring longer-term coverage options, including a separate model called BALANCE, but nothing is guaranteed yet. It's a good idea to discuss a long-term plan with your provider now, rather than waiting.

Who can I call if I have questions about my specific situation?

The Medicare Rights Center's free national helpline (800-333-4114) and your local State Health Insurance Assistance Program (SHIP, shiphelp.org) can offer free, confidential guidance tailored to your coverage.

Talk to Your Primary Care Provider

Whether or not you decide to pursue a GLP-1 medication, this news is a good reminder to check in on your overall health goals. Your primary care provider knows your history and can help you weigh the benefits, the realistic expectations, and the next steps that make the most sense for you.

If you have Medicare and think you might qualify for the GLP-1 Bridge Program, we encourage you to schedule an appointment with your Trinova Medical care team. We're here to answer your questions, help you understand your options, and support you in making the choice that's right for your health and your life.